Skip to main content

Table 1 Patient Characteristics

From: Validation of 24-hour ambulatory gait assessment in Parkinson's disease with simultaneous video observation

Subject ID Gender Age (yr) Disease Duration (yr) Levodopa Dose Equivalency (mg)
006 F 66 12 600
007* F 77 2 750
011* M 76 6 700
012* F 65 12 665
  1. Characteristics of the four Parkinson's disease patients at the time of the study. All four subjects performed the stride length validation. Three patients (denoted by '*' adjacent to subject ID) participated in the 24-h video validation.